ImmunoGen, Inc. (IMGN) Reports First Quarter Fiscal Year 2014 Financial Results and Provides Quarterly Update
10/25/2013 7:17:41 AM
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today reported financial results for the three-month period ended September 30, 2013 – the first quarter of the Company’s 2014 fiscal year.
Help employers find you! Check out all the jobs and post your resume.
comments powered by